The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity.
Open accessAbstract
Clonal expansion of CD4+ T cells is a characteristic finding in patients with RA and is only infrequently found in patients with psoriatic arthritis and healthy controls. Expanded CD4+ clonotypes are present in the blood, infiltrate into the joint, and persist over years. We have not addressed the question of whether the expanded clonotypes have unique functional and phenotypic properties which may explain the preferential in vivo expansion in RA. In contrast to most CD4+ T cells, expanded clonotypes lacked the expression of the CD28 and CD7 cell surface molecules. Accordingly, the subsets of CD4+ CD28- (9.7 vs 1.7, P = 0.00002) and CD4+ CD7- T cells (21.5 vs 12.26, P = 0.018) were increased in RA patients compared with age-matched normal individuals. Despite the lack of CD28 expression, clonally expanded CD4+ T cells were not anergic but proliferated in response to immobilized anti-CD3 and could be maintained in tissue culture. In vivo expanded CD4+ T cells were autoreactive to ubiquitously distributed autoantigens. They responded in an autologous mixed lymphocyte reaction, and T cell clones isolated from selected patients proliferated to autologous peripheral blood adherent cells. These data suggest that in RA patients selected CD4+ T cells which share the CD7- CD28- phenotype escape from peripheral tolerance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
Watanabe‐Fukunaga, R., Brannan, C., Copeland, N., Jenkins, N., & Nagata, S. (1992) · Nature · doi:10.1038/356314a0 · Cited by 3,153
Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)
Dhein, J., Walczak, H., Bäumler, C., Debatin, K., & Krammer, P. (1995) · Nature · doi:10.1038/373438a0 · Cited by 1,814
Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation
Ju, S., Panka, D., Cui, H., Ettinger, R., EI-Khatib, M., Sherr, D., Stanger, B., & Marshak-Rothstein, A. (1995) · Nature · doi:10.1038/373444a0 · Cited by 1,709
Epstein, F. H., & Harris, E. D. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005033221805 · Cited by 1,549
Brunner, T., Mogil, R. J., LaFace, D., Yoo, N. J., Mahboubi, A., Echeverri, F., Martin, S. J., Force, W. R., Lynch, D. H., Ware, C. F., et al. (1995) · Nature · doi:10.1038/373441a0 · Cited by 1,314
The Role of the CD28 Receptor During T Cell Responses to Antigen
Linsley, P. S., & Ledbetter, J. A. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.001203 · Cited by 1,298
Moskophidis, D., Lechner, F., Pircher, H., & Zinkernagel, R. M. (1993) · Nature · doi:10.1038/362758a0 · Cited by 1,240
CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL
Boise, L., Minn, A. J., Noel, P. J., June, C. H., Accavitti, M. A., Lindsten, T., & Thompson, C. B. (1995) · Immunity · doi:10.1016/1074-7613(95)90161-2 · Cited by 1,219
Apoptosis And Programmed Cell Death In Immunity
Cohen, J., Duke, R. C., Fadok, V. A., & Sellins, K. S. (1992) · Annual Review of Immunology · doi:10.1146/annurev.iy.10.040192.001411 · Cited by 1,112
Lantz, O. J., & Bendelac, A. S. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.3.1097 · Cited by 1,036
Cited by
Sorted by citations
Items 301–400 of 482
The initiation of the autoimmune response in multiple sclerosis
Markovic‐Plese, S., Pinilla, C., & Martinꝉ, R. (2004) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2004.02.018 · Cited by 24
Yang, H., Rittner, H. L., Weyand, C. M., & Goronzy, J. J. (1999) · Journal of Investigative Medicine · doi:10.1177/108155899904700511 · Cited by 24
Self-citationApoptotic effects of antilymphocyte globulins on human pro-inflammatory CD4+CD28- T-cells
Duftner, C., Dejaco, C., Hengster, P., Bijuklic, K., Joannidis, M., Margreiter, R., & Schirmer, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033939 · Cited by 23
Bortoluzzi, A., Chighizola, C. B., Fredi, M., Raschi, E., Bodio, C., Privitera, D., Gonelli, A., Silvagni, E., Govoni, M., Cavazzana, I., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.572876 · Cited by 24
The expansion of CD4+CD28− t cells in patients with chronic kidney graft rejection
Pawlik, A., Florczak, M., Masiuk, M., Dutkiewicz, E., Machaliński, B., Rozanski, J., Domański, L., & Gawronska-Szklarz, B. (2003) · Transplantation Proceedings · doi:10.1016/j.transproceed.2003.10.061 · Cited by 23
Taneja, V., Taneja, N., Behrens, M. D., Griffiths, M. M., Luthra, H. S., & David, C. S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.1118 · Cited by 23
Kosmaczewska, A., Ciszak, L., Stosio, M., Szteblich, A., Madej, M., Frydecka, I., Wiland, P., & Szmyrka−Kaczmarek, M. (2020) · Lupus · doi:10.1177/0961203320917749 · Cited by 22
Engineering Cell Therapies for Autoimmune Diseases: From Preclinical to Clinical Proof of Concept
Oh, S., & Payne, A. S. (2022) · Immune Network · doi:10.4110/in.2022.22.e37 · Cited by 22
Surface CD152 (CTLA-4) Expression and Signaling Dictates Longevity of CD28null T Cells
Hoff, H., Knieke, K., Cabail, Z., Hirseland, H., Vratsanos, G., Burmester, G. R., Jorch, G., Nadler, S. G., Bröker, B. M., Hebel, K., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801624 · Cited by 22
Reversal of T-cell tolerance in myelodysplastic syndrome through lenalidomide immune modulation
McDaniel, J. M., Zou, J., Fulp, W. J., Chen, D.-T., List, A. F., & Epling‐Burnette, P. K. (2011) · Leukemia · doi:10.1038/leu.2011.359 · Cited by 23
Graziani, F., Cialdella, P., Liuzzo, G., Basile, E., Brugaletta, S., Pedicino, D., Leccesi, L., Guidone, C., Iaconelli, A., Mingrone, G., et al. (2011) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2011.04.010 · Cited by 22
Kimoto, Y., Horiuchi, T., Tsukamoto, H., Kiyohara, C., Mitoma, H., Uchino, A., Furugo, I., Yoshizawa, S., Ueda, A., Harashima, S., et al. (2010) · Rheumatology · doi:10.1093/rheumatology/keq050 · Cited by 22
Antigen-specific T cells in rheumatoid arthritis
Bennett, S. R., Falta, M. T., Bill, J., & Kotzin, B. L. (2003) · Current Rheumatology Reports · doi:10.1007/s11926-003-0003-y · Cited by 22
Wu, T., Su, D., Zhang, L., Liu, T., Wang, Q., Yan, C., Liu, M., Ji, H., Lei, J., Zheng, M., et al. (2024) · Arthritis & Rheumatology · doi:10.1002/art.42954 · Cited by 21
Immunosenescence in autoimmune diseases
Hu, H., Zhang, G., Chen, T., Liu, Y., Meng, L., Holmdahl, R., Dai, L., & Zhao, Y. C. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103805 · Cited by 30
Demmers, M. W. H. J., Baan, C. C., Janssen, M., Litjens, N. H. R., IJzermans, J. N. M., Betjes, M. G. H., Weimar, W., & Rowshani, A. T. (2013) · Transplantation · doi:10.1097/01.tp.0000435697.31148.b2 · Cited by 21
Escarra‐Senmarti, M., Bueno‐Topete, M. R., Jave‐Suárez, L. F., Gómez-Bañuelos, E., Gutiérrez‐Franco, J., Vega‐Magaña, N., Aguilar‐Lemarroy, A., Pereira-Suárez, A. L., Haramati, J., & del Toro‐Arreola, S. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.01.006 · Cited by 21
Bailin, S. S., McGinnis, K. A., McDonnell, W. J., So‐Armah, K., Wellons, M., Tracy, R. P., Doyle, M. F., Mallal, S. A., Justice, A. C., Freiberg, M. S., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa069 · Cited by 21
Splenic Lymphoid Subsets With Less Well-Recognized Phenotypes Mimic Aberrant Antigen Expression
Aggarwal, N., Fischer, J., Swerdlow, S. H., & Craig, F. E. (2013) · American Journal of Clinical Pathology · doi:10.1309/ajcppibh3i1vrwxq · Cited by 21
Schultz, D. R., & Diego, J. M. (2000) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(00)80014-1 · Cited by 21
Impaired Expression of CD28 on T Cells in Hairy Cell Leukemia
van de Corput, L., Falkenburg, J. H. F., Kester, M. G. D., Willemze, R., & Kluin‐Nelemans, H. C. (1999) · Clinical Immunology · doi:10.1006/clim.1999.4794 · Cited by 21
Bailin, S. S., Kundu, S., Wellons, M., Freiberg, M. S., Doyle, M. F., Tracy, R. P., Justice, A. C., Wanjalla, C. N., LANDAY, A. L., So‐Armah, K., et al. (2021) · AIDS · doi:10.1097/qad.0000000000003137 · Cited by 20
Folliculotropic T-Cell Lymphocytosis as a Distinct Form of Pilotropic T-Cell Dyscrasia
MAGRO, C. M. J., & CROWSON, A. N. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcpbii68ijxuxhc · Cited by 19
Mitochondrial Antigens as Targets of Cellular and Humoral Auto-Immunity in Primary Biliary Cirrhosis
Ichiki, Y., Selmi, C. F., Shimoda, S., Ishibashi, H., Gordon, S. C., & Gershwin, M. E. (2005) · Clinical Reviews in Allergy & Immunology · doi:10.1385/criai:28:2:083 · Cited by 19
Killer Cell Immunoglobulin-like Receptors Influence the Innate and Adaptive Immune Responses.
Rajalingam, R. (2007) · PubMed · doi:10.22034/iji.2007.17182 · Cited by 19
Cytotoxic CD4+ T cells: origin, biological functions, diseases and therapeutic targets
Lai, L., Ran, S., Li, Y., Cui, J., Zhang, X., Yu, J., Zou, Y., Cheng, Z., Xia, J., & Wu, J. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02533-z · Cited by 24
Aging-associated immune system changes in multiple myeloma: The dark side of the moon.
Visram, A., & Kourelis, T. (2021) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2021.100494 · Cited by 20
Fonseka, C. Y., Rao, D. A., & Raychaudhuri, S. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.08.005 · Cited by 18
Yang, J., Lickliter, J. D., Hillson, J., Means, G., Sanderson, R. J., Carley, K., Tercero, A., Manjarrez, K. L., Wiley, J. R., & Peng, S. L. (2021) · Clinical and Translational Science · doi:10.1111/cts.12983 · Cited by 18
Pierer, M., Rossol, M., Kaltenhäuser, S., Arnold, S., Häntzschel, H., Baerwald, C., & Wagner, U. G. (2010) · Rheumatology International · doi:10.1007/s00296-010-1402-9 · Cited by 18
Iwaszko, M., Świerkot, J., Dratwa, M., Wysoczańska, B., Korman, L., Bugaj, B., Kolossa, K., Jeka, S., Wiland, P., & Bogunia‐Kubik, K. (2020) · The Pharmacogenomics Journal · doi:10.1038/s41397-020-0164-3 · Cited by 18
Flow Cytometric Analysis of Human Antigen-Specific T-Cell Proliferation
Brenchley, J. M., & Douek, D. C. (2004) · Methods in cell biology · doi:10.1016/s0091-679x(04)75019-0 · Cited by 18
Dillon, S. R., Evans, L. S., Lewis, K. E., Debrot, S., Blair, T. C., Mudri, S., Kleist, K. N., Levin, S. D., Bhandari, J. G., Garrett, L., et al. (2023) · Arthritis & Rheumatology · doi:10.1002/art.42484 · Cited by 17
Frequency and characteristics of circulating CD4+ CD28null T cells in patients with psoriasis
Lima, X. T. V., Cintra, M. L., Piaza, A. C. S., Mamoni, R. L., de Oliveira, R. T. D., Magalhães, R. F., & Blotta, M. H. S. L. (2015) · British Journal of Dermatology · doi:10.1111/bjd.13993 · Cited by 17
CD4+ count‐dependent concentration–effect relationship of rituximab in rheumatoid arthritis
Bensalem, A., Mulleman, D., Thibault, G., Azzopardi, N., Goupille, P., Paintaud, G., & Ternant, D. (2019) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14102 · Cited by 17
The pathogenic role of rheumatoid factor in rheumatoid arthritis
Song, Y. W., & Kang, E. H. (2010) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.10.62 · Cited by 17
Mima, T., Ohshima, S., Sasai, M., Nishioka, K., Shimizu, M., Murata, N., Yasunami, R., Matsuno, H., Suemura, M., Kishimoto, T., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1128 · Cited by 17
New insights into immune cells cross-talk during IgG4-related disease
Touzani, F., & Pozdzik, A. A. (2018) · Clinical Immunology · doi:10.1016/j.clim.2018.11.004 · Cited by 16
Immune Cells Profiling in ANCA-Associated Vasculitis Patients—Relation to Disease Activity
Żabińska, M., Kościelska−Kasprzak, K., Krajewska, J., Bartoszek, D., Augustyniak‐Bartosik, H., & Krajewska, M. (2021) · Cells · doi:10.3390/cells10071773 · Cited by 16
Monserrat, J., Heras, C. B., Gomez-Lahoz, A. M., Movasat, A., Pérez, A., Ruiz, L., Díaz, D., Chara, L. E., Sánchez, A. I., Albarrán, F., et al. (2019) · Cells · doi:10.3390/cells8080871 · Cited by 16
Clonal Populations of T-Cells in Patients with B-Cell Malignancies
Moss, P. A. H., & Gillespie, G. M. A. (1997) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199709059679 · Cited by 16
Mitsui, T., Maekawa, I., Yamane, A., Ishikawa, T., Koiso, H., Yokohama, A., Handa, H., Matsushima, T., Tsukamoto, N., Murakami, H., et al. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05005.x · Cited by 16
TNFα polymorphism as marker of immunosenescence for rheumatoid arthritis patients
Rodríguez‐Carrio, J., Alpéri, M., López, P., Alonso-Castro, S., Ballina‐García, F. J., & Suárez, A. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.12.009 · Cited by 15
Wahlin, B., Fasth, A. E. R., Karp, K. H., Lejon, K., Malmström, V., Rahbar, A., Wållberg‐Jonsson, S., & Södergren, A. (2021) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/gs3o43 · Cited by 15
Wang, Q., Che, N., Lu, C., Sun, X., Wang, Y., Wang, Q., Tan, W., Zhou, L., Zhang, X., Xu, D., et al. (2021) · Arthritis Research & Therapy · doi:10.1186/s13075-021-02632-6 · Cited by 15
Bremer, E., Abdulahad, W. H., de Bruyn, M., Samplonius, D. F., Kallenberg, C. G. M., Armbrust, W., Brouwers, E., Wajant, H., & Helfrich, W. (2011) · Immunology Letters · doi:10.1016/j.imlet.2011.04.004 · Cited by 15
Fateminasab, F. D., Shahgasempour, S., Mirsaeidi, M. S., Tabarsi, P., Mansoori, S. D., & Entezami, Z. (2006) · PubMed · Cited by 15
Role of unusual CD4+ CD28− T cells in acute coronary syndrome
Sun, W., Zheng, L., & Huang, L. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-1103-9 · Cited by 14
Filén, J., Nyman, T. A., Korhonen, J. T., Goodlett, D. R., & Lahesmaa, R. (2005) · PROTEOMICS · doi:10.1002/pmic.200402016 · Cited by 15
Targeting Inflammation: Impact on Atherothrombosis
Marini, M. G., Sonnino, C., Previtero, M., & Biasucci, L. M. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-013-9523-7 · Cited by 14
Breast abscess due to Salmonella Typhimurium in a patient with rheumatoid arthritis: a case report
Baran, I., Aksu, N., & Aksoy, A. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1659-z · Cited by 14
Rappl, G., Abken, H., Hasselmann, D. O., Tilgen, W., Ugurel, S., & Reinhold, U. (2001) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400825 · Cited by 14
Kagan, J. (2002) · Disease Markers · doi:10.1155/1998/698239 · Cited by 1
Pathogenesis of giant cell arteritis with focus on cellular populations
Stamatis, P., Turesson, C., Michailidou, D., & Mohammad, A. J. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1058600 · Cited by 14
Chain, J. L., Martin, A. D., Mack, D. G., Maier, L. A., Palmer, B. E., & Fontenot, A. P. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300282 · Cited by 13
Davignon, J., Boyer, J., Jamard, B., Nigon, D., Constantin, A., & Cantagrel, A. G. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3083 · Cited by 13
T Cell Homeostasis and Autoreactivity in Rheumatoid Arthritis
Goronzy, J. J., & Weyand, C. M. (2000) · KARGER eBooks · doi:10.1159/000060516 · Cited by 13
Self-citationBakakos, P., Pickard, C., Wong, W., AYRE, K. R., Madden, J., Frew, A. J., HODGES, E., CAWLEY, M. I. D., & SMITH, J. L. (2002) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2002.01868.x · Cited by 13
Lee, G. H., Lee, J. Y., Jang, J., Kang, Y. J., Choi, S. A., Kim, H. C., Park, S., Kim, M. S., & Lee, W. (2022) · Clinical & Translational Immunology · doi:10.1002/cti2.1431 · Cited by 12
van Laar, J. M. (2000) · Arthritis Research · doi:10.1186/ar101 · Cited by 12
Tang, X., Yocum, D. E., Dejonghe, D., Nordensson, K., Lake, D. F., & Richard, J. W. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01888.x · Cited by 12
Mack, D. G., Lanham, A. K., Palmer, B. E., Maier, L. A., Watts, T. H., & Fontenot, A. P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.4381 · Cited by 12
T cell receptor usage in autoimmune disease
Moss, P. A. H., & Bell, J. I. (1999) · Springer Seminars in Immunopathology · doi:10.1007/bf00815175 · Cited by 12
Quantitative alterations of CD8+ T cells in juvenile idiopathic arthritis patients in remission
Prelog, M., Schwarzenbrunner, N., Tengg, E., Sailer‐Höck, M., Kern, H., Zimmerhackl, L. B., & Brunner, J. (2008) · Clinical Rheumatology · doi:10.1007/s10067-008-1057-z · Cited by 10
The role of KIR2DL3/HLA-C*0802 in Brazilian patients with rheumatoid vasculitis
Nishimura, W. E., Sachetto, Z., Costallat, L. T. L., Yazbek, M. A., Londe, A. C., Guariento, E. G., Marques, S. B. D., & Bértolo, M. B. (2015) · Clinics · doi:10.6061/clinics/2015(06)04 · Cited by 11
Hirokawa, M., Horiuchi, T., Kawabata, Y., Kitabayashi, A., Saitoh, H., Ichikawa, Y., Matsutani, T., Yoshioka, T., Tsuruta, Y., Suzuki, R., et al. (2001) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703045 · Cited by 11
Mariaselvam, C. M., Boukouaci, W., Charron, D. J., Krishnamoorthy, R., Tamouza, R., Misra, D. P., & Negi, V. S. (2017) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13138 · Cited by 11
Li, N., Ji, P., Song, L., Lei, J., Lv, Z., Wu, Z., Shao, X., & Sun, X. (2015) · Parasitology Research · doi:10.1007/s00436-015-4507-y · Cited by 11
Immunosenescence: Molecular Mechanisms, Diseases, and Therapeutic Innovations
Gong, N., Pan, X., Deng, Y., Che, J., Bao, J., Wang, M., Xu, C., Liu, X., & Shi, Y. (2025) · MedComm · doi:10.1002/mco2.70515 · Cited by 14
Calvo‐Barreiro, L., Nada, H., Upadhyay, S., & Gabr, M. T. (2025) · ACS Omega · doi:10.1021/acsomega.5c10222 · Cited by 10
The clinical importance of CD4 + CD7 − in human diseases
Haftcheshmeh, S. M., Tajbakhsh, A., Kazemi, M., Esmaeili, S., Mardani, F., Fazeli, M., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27099 · Cited by 10
Kosmaczewska, A., Ciszak, L., Świerkot, J., Szteblich, A., Wiland, P., & Frydecka, I. (2013) · Pathology & Oncology Research · doi:10.1007/s12253-013-9687-0 · Cited by 10
CD4+T-cell subsets in rheumatoid arthritis
Ponchel, F., Vital, E. M. J., Kingsbury, S. R., & El-Sherbiny, Y. M. (2012) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.11.69 · Cited by 10
Functional integrity of the CD28 co-stimulatory pathway in T lymphocytes from elderly subjects
Vidán, M. T. (1999) · Age and Ageing · doi:10.1093/ageing/28.2.221 · Cited by 10
Saxena, A., Raychaudhuri, S. P., & Raychaudhuri, S. P. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397803-5.00018-6 · Cited by 9
ABATACEPT FOR RHEUMATOID ARTHRITIS: A NOVEL FORMULATION, NEW MECHANISMS, NEW POSSIBILITIES
Nasonov, E. L. (2015) · Rheumatology Science and Practice · doi:10.14412/1995-4484-2015-522-541 · Cited by 9
Bosch, J. A., Rector, J. L., Turner, J. E., Riddell, N. E., O’Hartaigh, B. W. J., & Burns, V. E. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4776-4_6 · Cited by 9
Co-stimulation Therapy in Rheumatoid Arthritis: Today and Tomorrow
Schiff, M. H. (2015) · Current Treatment Options in Rheumatology · doi:10.1007/s40674-015-0029-0 · Cited by 9
Physiology and Pathology of Autoimmune Diseases: Role of CD4+ T cells in Rheumatoid Arthritis
Castro-Sánchez, P., & Roda‐Navarro, P. (2017) · InTech eBooks · doi:10.5772/intechopen.70239 · Cited by 11
Wagner, U. G. (2011) · Springer eBooks · doi:10.1007/978-3-0346-0219-8_7 · Cited by 9
Human IgG1 antibodies antagonizing activating receptor NKG2D on natural killer cells
Steigerwald, J., Raum, T., Pflanz, S., Cierpka, R., Mangold, S., Rau, D., Hoffmann, P., Kvesic, M., Zube, C., Linnerbauer, S., et al. (2009) · mAbs · doi:10.4161/mabs.1.2.7630 · Cited by 9
CD57+ Cells and Recurrent Spontaneous Abortion
Winger, E. E. (2007) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2007.00505.x · Cited by 9
Kato, M., Matsuguchi, T., Ono, Y., Hattori, R., Ohshima, S., & Yoshikai, Y. (2001) · Human Immunology · doi:10.1016/s0198-8859(01)00353-6 · Cited by 9
CD7 − T Cells are Late Memory Cells Generated from CD7 + T Cells
Rappl, G., Schrama, D., Hombach, A. A., Meuer, E., Schmidt, A., Becker, J. C., & Abken, H. (2008) · Rejuvenation Research · doi:10.1089/rej.2007.0612 · Cited by 9
Senescent CD4+ T cells and autoimmune diseases: mechanisms and therapeutic prospects
Hu, Y., He, L., & Long, H. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103957 · Cited by 10
Lehoczki, A., Ungvari, Z. I., Szappanos, Á., Fekete, M., Gunkl-Tóth, L., & Nagy, G. (2025) · GeroScience · doi:10.1007/s11357-025-02049-y · Cited by 10
Endogenous antigens shape the transcriptome and TCR repertoire in an autoimmune arthritis model
McCarthy, E. E., Yu, S., Perlmutter, N., Nakao, Y., Naito, R., Lin, C., Riekher, V., DeRisi, J. L., Ye, C., Weiss, A., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci174647 · Cited by 8
Autologous Mixed Lymphocyte Responses in Experimentally-induced Arthritis of the Lewis Rat
Catchpole, B., Hamblin, A. S., & Staines, N. A. (2002) · Autoimmunity · doi:10.1080/08916930290016619 · Cited by 8
Sun, H. S., Liu, D. X., Bai, Y. Y., & Hu, N. W. (2018) · Modern Rheumatology · doi:10.1080/14397595.2018.1483292 · Cited by 8
Progress and unmet needs in understanding fundamental mechanisms of autoimmunity
Reynolds, J. A., & Putterman, C. (2023) · Journal of Autoimmunity · doi:10.1016/j.jaut.2023.102999 · Cited by 7
Rheumatoid Arthritis—Heresies and Speculations
Fox, D. A. (1997) · Perspectives in biology and medicine · doi:10.1353/pbm.1997.0061 · Cited by 7
Beck, F., Nguyen, P., Hoffmann, A., Loyal, L., Thiel, A., Melzer, M., Apel, H., Pierer, M., Krasselt, M., Seifert, O., et al. (2024) · Arthritis & Rheumatology · doi:10.1002/art.42960 · Cited by 9
Jadhav, R. R., Hu, B., Ye, Z., Sheth, K., Li, X., Greenleaf, W. J., Weyand, C. M., & Goronzy, J. J. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103825 · Cited by 7
Self-citationRothe, K., Raulien, N., Köhler, G., Pierer, M., Quandt, D., & Wagner, U. G. (2017) · European Journal of Immunology · doi:10.1002/eji.201646747 · Cited by 7
Catchpole, B., Ward, F. J., Hamblin, A. S., & Staines, N. A. (2002) · Journal of Autoimmunity · doi:10.1006/jaut.2002.0585 · Cited by 6
Immunosenescence in multiple sclerosis: New insights and clinical implications
Laroni, A., Vigo, T., Inglese, M., & Uccelli, A. (2025) · Multiple Sclerosis Journal · doi:10.1177/13524585251367611 · Cited by 6
Accelerated T-cell senescence and persistent inflammation in older adults with rheumatoid arthritis
Cezar, C. D., Scholl, J. N., Rabelo, C. F., Madruga, M. P., Silva, P. L., Grün, L. K., Engroff, P., Bressanim, A. C. M., Scherer, R. T., Schwanke, C. H. A., et al. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115518 · Cited by 5
Immune responses in aging adults
Weyand, C. M., & Goronzy, J. J. (2026) · Journal of Clinical Investigation · doi:10.1172/jci206227 · Cited by 5
Self-citationInvolvement of expanded cytotoxic and proinflammatory CD28null T cells in primary Sjögren's syndrome
Deng, C., Wang, A., Li, W., Zhao, L., Zhou, J., Zhang, W., Li, M., & Fei, Y. (2024) · Clinical Immunology · doi:10.1016/j.clim.2024.109927 · Cited by 5
Wagner, U. G., & Krasselt, M. (2014) · Osteologie/Osteology · doi:10.1055/s-0037-1622017 · Cited by 5
Metadata
- Authors
- Schmidt, D., Goronzy, J. J., & Weyand, C. M.
- Affiliations
- Mayo Clinic (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1996-05-01
- Volume
- 97
- Issue
- 9
- Pages
- 2027-2037
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC507276
- OpenAlex
- W1982865105
- Cited by
- 482
- References
- 43
- Citations by year
- 2026: 3 · 2025: 11 · 2024: 10 · 2023: 5 · 2022: 13 · 2021: 15 · 2020: 12 · 2019: 15 · 2018: 10 · 2017: 18 · 2016: 7 · 2015: 20 · 2014: 12 · 2013: 23 · 2012: 11
- FWCI
- 18.26
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Arthritis Foundation
- Mayo Foundation for Medical Education and Research
- National Institutes of Health
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR041974, R01 AR 41974, R01AR042527, R01AR42527)
- Topics
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- rheumatoid arthritis, CD4+ T cells, clonal expansion, CD28, CD7, autoreactivity, peripheral tolerance, T cell anergy, autoantigens, mixed lymphocyte reaction, T cell proliferation, psoriatic arthritis
- MeSH terms
- Arthritis, Rheumatoid, Autoantigens, Base Sequence, Clone Cells, Humans, Lymphocyte Activation, Molecular Sequence Data, CD4-Positive T-Lymphocytes, Immunophenotyping, T-Lymphocyte Subsets, CD28 Antigens, Antigens, CD7
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review